The Purpose Of This Tender Procedure Is The Contracting Of The Pet-Mri Service With Psma 1007 Aimed At The Detection Of Clinically Significant Prostate Cancer In Men Carriers Of Mutations In The Brca Gene To Carry Out Project Pi23/01310 Entitled "Incorporation Of Imaging Methods And Molecular Profiles To Improve Prostate Cancer Screening In Carriers Of Mutations In Dna Repair Pathway Genes", Carried Out By The Urology Biomedical Research Group Of The Vall Hebron University Hospital Foundation - Research Institute (Vhir), Financed By The Carlos Iii Health Institute (Isciii) And Co-Financed By The European Union Through Feder.

Fundacio Hospital Universitari Vall d'Hebron - Institut de Recerca Spain has Released a tender for The Purpose Of This Tender Procedure Is The Contracting Of The Pet-Mri Service With Psma 1007 Aimed At The Detection Of Clinically Significant Prostate Cancer In Men Carriers Of Mutations In The Brca Gene To Carry Out Project Pi23/01310 Entitled "Incorporation Of Imaging Methods And Molecular Profiles To Improve Prostate Cancer Screening In Carriers Of Mutations In Dna Repair Pathway Genes", Carried Out By The Urology Biomedical Research Group Of The Vall Hebron University Hospital Foundation - Research Institute (Vhir), Financed By The Carlos Iii Health Institute (Isciii) And Co-Financed By The European Union Through Feder. in Healthcare Equipment and Services. The tender was released on Aug 27, 2024.

Country - Spain

Summary - The Purpose Of This Tender Procedure Is The Contracting Of The Pet-Mri Service With Psma 1007 Aimed At The Detection Of Clinically Significant Prostate Cancer In Men Carriers Of Mutations In The Brca Gene To Carry Out Project Pi23/01310 Entitled "Incorporation Of Imaging Methods And Molecular Profiles To Improve Prostate Cancer Screening In Carriers Of Mutations In Dna Repair Pathway Genes", Carried Out By The Urology Biomedical Research Group Of The Vall Hebron University Hospital Foundation - Research Institute (Vhir), Financed By The Carlos Iii Health Institute (Isciii) And Co-Financed By The European Union Through Feder.

Deadline - Sep 10, 2024

GT reference number - 91475579

Product classification - Health services